the results indicate that pre-screening for differentiation-inducing compounds and compounds that show toxicity to blast cells should be useful to select the appropriate compounds to be used for therapy , and that it is advisable to screen the cells both before and after initiation of therapy .
C0007589
differentiation
C0007634
cells